Publications by authors named "Chloe Stavris"

Claim this Profile
C
Consequences of sarcolemma fatigue on maximal muscle strength production in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Frédérique Retornaz, Chloé Stavris, Yves Jammes

Clin Biomech (Bristol)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?
Philippe Halfon, Sylvie Jordana, Stéphane Blachier, Philippe Cartlamy, Laurent Kbaier, Chloé Stavris

PLoS One· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Expertise for management of immune-related adverse events in cancer therapy].
Mathias Thomas, Amélie Rognon, Thomas Escoda, Chloé Stavris, Laurent Chiche

Bull Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
Frédérique Retornaz, Stanislas Rebaudet, Chloé Stavris, Yves Jammes

J Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypnotherapy in Treatment of Mastocytosis: A Prospective Study.
Frédérique Retornaz, Michel Grino, Audrey Vanhaudenhuyse, Laurent Chiche, Chloé Stavris

Int J Clin Exp Hypn· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results.
Philippe Halfon, Christelle Ansaldi, Guillaume Penaranda, Laurent Chiche, Patrick Dukan, Chloé Stavris

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach.
Fabien Grimaud, Guillaume Penaranda, Chloé Stavris, Frédérique Retornaz, Véronique Brunel

Ther Clin Risk Manag· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered muscle membrane potential and redox status differentiates two subgroups of patients with chronic fatigue syndrome.
Yves Jammes, Nabil Adjriou, Nathalie Kipson, Christine Criado, Caroline Charpin, Chloé Stavris

J Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximal handgrip strength can predict maximal physical performance in patients with chronic fatigue.
Yves Jammes, Chloé Stavris, Caroline Charpin, Stanislas Rebaudet, Gerard Lagrange

Clin Biomech (Bristol)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.
Alice Tison, Gilles Quéré, Laurent Misery, Elisa Funck-Brentano, François-Xavier Danlos, Chloé Stavris

Arthritis Rheumatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
Patrick Philibert, Laurent Chiche, Sylvie Caillères, Julie Allemand, Stanislas Rebaudet, Chloé Stavris

AIDS· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunistic autoimmunity secondary to immunotherapy and melanoma: Back to ABCDE?
Marie Kostine, Chloé Stavris, Laurent Chiche

Eur J Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis